Clinical Trials

6 enrolled

Stomach Neoplasms

NCT04999332 2023-11-15

LOTS

58 enrolled

Stomach Neoplasms

NCT02191566 2022-12-08

SOHUG

Phase 2 Terminated

8 enrolled

Stomach Neoplasms

NCT00429858 2020-09-18

Gemcitabine and S-1 for Locally Advanced Unresectable or Metastatic Pancreatic Cancer

Phase 2 Terminated

21 enrolled 8 charts

Pancreatic Neoplasms

NCT01283204 2019-01-29

Trial of 4-regimen (SP, FL/Tax, FL/Doc, FOLFOX) in Patients With Recurrent or Metastatic Gastric Cancer

180 enrolled

Recurrence, Stomach Neoplasms

NCT01430052 2017-11-21

Chemoradiotherapy With Gemcitabine/S-1 vs Gemcitabine/S-1 for Locally Advanced Pancreatic Cancer

110 enrolled

Pancreatic Neoplasms

NCT03316326 2017-10-20

S-1, Irinotecan, and Oxaliplatin in Locally-Advanced Pancreatic Cancer

35 enrolled

Pancreatic Ductal Adenocarcinoma

NCT01693419 2017-08-23

S-1, Gemcitabine and Erlotinib for Advanced Pancreatic Cancer

37 enrolled

Pancreatic Neoplasms

NCT01693432 2017-08-23

Docetaxel and S-1 for Advanced Esophageal Cancer

37 enrolled

Esophageal Neoplasms

NCT02527785 2017-08-23

Study of Oxaliplatin, Irinotecan, and S-1 in Gastric Cancer

44 enrolled

Stomach Neoplasms

NCT02870153 2016-08-19

SOX Versus XELOX for Patients With Peritoneal Metastasis of Colorectal Cancer

60 enrolled

Colorectal Neoplasms

NCT01100801 2016-06-22

3G

90 enrolled

Neoplasm Metastasis, Stomach Neoplasms

NCT02754180 2016-04-28

Adjuvant Gemcitabine Versus Gemcitabine With Chemoradiation in Pancreatic Adenocarcinoma With R1 Resection and/or Positive Lymph Nodes

110 enrolled

Pancreatic Neoplasms

NCT00438100 2015-05-29

Capecitabine vs. S-1 in Unresectable or Recurrent Breast Cancer

142 enrolled 4 charts

Breast

Breast Neoplasms

NCT01679340 2015-05-19

A PhaseⅡ Study: SOX vs SP in Adjuvant Chemotherapy After D2 Surgery

160 enrolled

Stomach Neoplasms

NCT01269216 2015-01-28

A Study of Neoadjuvant Chemoradiotherapy With 5-FU/Leucovorin (FL) vs. TS-1/Irinotecan in Patients With Locally Advanced Rectal Cancer

136 enrolled

Rectal Neoplasms

NCT02146703 2014-05-26

Gemcitabine and S-1 for Advanced Biliary Tract Cancer

38 enrolled

Biliary Tract Neoplasms

NCT00527930 2013-10-10

TORCH

87 enrolled

Breast

Breast Neoplasms

NCT01824004 2013-04-04

Postoperative Chemoradiotherapy With S-1 in Gastric Cancer

46 enrolled

Stomach Neoplasms

NCT00677144 2012-10-05

Oxaliplatin and S-1 (OS) Versus Oxaliplatin and Capecitabine (XELOX) for Advanced Colorectal Cancer

88 enrolled

Colorectal Neoplasms

NCT00525005 2012-09-21

Docetaxel, Oxaliplatin and S-1 (DOS) for Advanced Gastric Cancer

44 enrolled

Stomach Neoplasms

NCT01645748 2012-07-20

TPSHNSCC

35 enrolled

Head & Neck

Head and Neck Neoplasms

NCT01608646 2012-05-31

Study of DPD for Predicting Efficacy and Safety to S-1 Plus Oxaliplatin in Gastrointestinal Cancer

200 enrolled

Gastrointestinal Neoplasms

NCT01533324 2012-02-15

S-1/LV One Week on and One Week Off Regimen in Advanced Hepatocellular Carcinoma (HCC)

32 enrolled

Carcinoma, Carcinoma, Hepatocellular, Liver Diseases

NCT01426646 2012-01-05

S-1 Versus S-1 Plus Cisplatin as an Adjuvant Chemotherapy to Treat Gastric Cancer

218 enrolled

Stomach Neoplasms

NCT00514163 2011-06-28

GEM vs GEM+TS-1 for Advanced Pancreatic Cancer

110 enrolled

Pancreatic Neoplasms

NCT01096745 2011-06-23

Randomized Trial of Gemcitabine/Cisplatin Versus S-1/Cisplatin in Advanced Biliary Cancer

Phase 2 Terminated

78 enrolled

Bile Duct Neoplasms, Biliary Tract Neoplasms

NCT00961077 2009-08-18

Attenuated SOX as First-line Treatment in Elderly Patients With Relapsed or Metastatic Gastric Cancer

36 enrolled

Recurrence, Stomach Neoplasms

NCT00209651 2007-11-01

Phase II Study of Oral S-1 Plus Irinotecan (IRIS) in Patients With Advanced Colorectal Cancer

40 enrolled

Colorectal Neoplasms

NCT00436423 2007-11-01

A Phase Ⅱ Study of Gemcitabine Combination With TS-1 in Patient With Advanced or Recurred Pancreatic Cancer

38 enrolled